GfK at ISPOR: Exploring the evolving value story in healthcare

Meet our Market Access Experts at ISPOR’s 20th Annual European Congress November 4-8 in Glasgow

 

We invite you to meet our market access specialists in Booth #207 to join the discussion on the evolving value story in healthcare.

Additionally, stop by to explore our poster presentations, which cover the most relevant and top-of-mind topics:

  1. Price-dose relationship: The case of oral oncology drugs in EU5
  2. Technical challenges in cost-effectiveness analysis for oncology treatments: Identifying frequent issues in modeling from NICE perspective
  3. Analysis of the G-BA decision-making criteria on the benefit assessment of diabetes treatments: Is cost an influencing criterion?
  4. Patient input into value assessment of respiratory medicines: What lessons can be learned from existing value frameworks in other disease areas
  5. Clinical and cost impact of a novel non-invasive approach for the treatment of cervical dysplasia from a US payer perspective
  6. Affordability and WTP challenges of combinations of high-value/high-priced products in oncology – identifying solutions for immunotherapies, precision medicines and antibody drug conjugates
  7. Retrospective analysis of the CEESP efficiency opinions and eligibility criteria for assessment since its creation
  8. Identification of assessment and funding models applicable to companion diagnostics in UK, France and Germany
  9. Does the reimbursement of in-patient hospital services adequately cover novel antibiotic pharmaceuticals in the US, EU4 and England? Discussion of current mechanisms in place

We invite you to join us for a meeting onsite or simply a chat over coffee during the program.

171018_GfK_ISPOR_Glasgow_1180x350px.png